INTRODUCTION {#sec1-1}
============

There are approximately 1.6 billion Muslims worldwide. Ramadan, the ninth lunar month, is the holiest month in the Islamic calendar. During this month, millions of Muslims fast from dawn to sunset each day.[@ref1] Studies of fasting commonly distinguish between caloric restriction (CR), alternate-day fasting (ADF), and dietary restriction (DR). Ramadan fasting is considered similar to ADF because both incorporate alternating feast periods and fast periods.[@ref2]

Areas of the world with large Muslim populations, such as the Middle East and South Asia, bear a heavy burden with respect to cardiometabolic disease and cardiovascular risk factors, such as diabetes mellitus.[@ref3],[@ref4] While doctrine exempts people with significant illness from the obligation of Ramadan fasting, many Muslim patients nevertheless have a strong desire to participate. This raises general concerns regarding safety. It also raises more specific questions regarding outcomes and necessary precautions if these patients complete fasting for the full month.

The literature on the effects of Ramadan fasting on cardiovascular outcomes and related factors are controversial. Fasting in Ramadan has been associated with both negative and positive effects in individuals with cardiovascular disease or cardiometabolic risk factors.[@ref1],[@ref4] In this review, we aimed to analyze the available literature on the effects of Ramadan fasting on cardiovascular outcomes in patients with a history of cardiovascular disease, as well as the effect of fasting on cardiometabolic risk factors such as circulating lipids.

METHODS {#sec1-2}
=======

A comprehensive search strategy was developed for original articles published in peer-reviewed journals, using terms related to the impact of Ramadan fasting on cardiovascular outcomes, risk factors and body composition. The following electronic databases were searched: MEDLINE, Scopus and Web of Knowledge from 1982 up to 2014.

Search was conducted using the search term: ("Ramadan" OR "Islamic fasting" OR "Muslim fast" OR "Islamic fast" OR "Islam fast") AND ("Body weight" OR "weight reduction" OR "weight loss" OR "weight gain" OR "body mass index" OR "body composition" OR "BMI" OR "body water" OR "blood pressure" OR "waist circumference" OR "energy intake" OR "carbohydrate intake" OR "protein intake" OR "fat intake" OR "total cholesterol" OR "triglycerides" OR "high density lipoproteins" OR "low density lipoproteins" OR "very low density lipoproteins" OR "blood pressure" OR "pulse pressure" OR "cardiovascular diseases'' OR "heart diseases" OR "stroke" OR " heart failure" OR " acute myocardial infarction" OR "cardiac care unit" OR "coronary heart diseases").

Further articles were identified by examining the reference lists of identified articles and through the Science Citation Index. The search was limited to full papers published in the English language with no limit on the date of publication.

The identified studies were reviewed and articles were included in the analysis if they reported the effects of Ramadan fasting on cardiovascular outcomes, such as myocardial infarction, cardiac revascularization, heart failure or stroke, or on cardiometabolic risk factors such as body mass index (BMI), blood pressure (BP) or lipid profiles. Editorials and review articles were excluded, as were abstracts not associated with a full, original article. Studies concerned with the effects of fasting on groups not representative of a broad patient population (for example, athletes) were also excluded.

Following this initial process of filtering, the full text of the remaining papers was further reviewed. Case series, cohort studies and randomized studies were considered eligible for inclusion in the final analysis. Eligibility was determined by two reviewers (M.M. and M.S.), and differences of opinion settled following discussion.

RESULTS {#sec1-3}
=======

Just some studies were considered eligible for review. These studies may be grouped into those that considered cardiovascular outcomes, and those that considered risk factors alone.

Cardiovascular Outcomes {#sec2-1}
-----------------------

No study was large enough in scope to consider the effects of Ramadan fasting on cardiovascular outcomes in disease naïve individuals, in people with established cardiovascular disease. However, a number of studies reported no effect of fasting during Ramadan on stroke, hospitalization for heart failure, acute myocardial infarction (AMI), the incidence of angina pain, coronary artery diseases and valvualr heart disease in patients with stable cardiovascular diseases.[@ref5]-[@ref8]

A retrospective study from Turkey appeared to show a deleterious effect of Ramadan fasting on the incidence of stroke in patients with diabetes mellitus.[@ref9] However, other studies[@ref7],[@ref10] have failed to show a difference.

Furthermore, although one study[@ref11] reported a decreased incidence of unstable angina and acute myocardial infarction during Ramadan fasting, this finding has not been replicated subsequently and collectively the results of this review showed no significant differences in the incidence of AMI or angina during Ramadan when compared to the rest of the year. For example, Chamsi-Pasha et al.[@ref5] carried out a prospective study on eighty-six outpatients with heart disease who were intending to fast. Forty-six patients (53%) had coronary artery disease, 23 patients (27%) had valvular heart disease, 13 patients (15%) had congestive heart failure and 4 patients (5%) were treated for arrhythmia. The results indicated that the effects of fasting during Ramadan on stable patients with cardiac disease were minimal.

###### 

Cardiovascular disease and cardiometabolic risk factors.

  Article         Subject's characteristics   Outcomes                                                                                    
  --------------- --------------------------- ---------- -------- -------- ------------ -------------- ---- ---- ---- ---- ---- ---- ---- ----
  Temizhan A.     1991-1997                   1999       Turkey   NM       NM           NM             ↓    NM   NM   NM   NM   NM        
  Akhan J.        1991-1995                   2000       Turkey   230000   \>25         NM             NM   NM   NM   \-   NM   NM        
  Comoglu         2003                        2003       Turkey   126      137          63.9±11.2      NM   NM   NM   NM   ↓    ↑    NM   NM
  Al Suwaidi J.   1991-2001                   2004       Qatar    20 856   NM           NM             \-   \-   NM   NM   NM   NM   NM   
  Al Suwaidi J.   2004                        2004       Qatar    5095     3351         NM             \-   NM   NM   NM   NM   NM   NM   
  Ch-Pasha H.     1996                        2004       KSA      54       32           56.3 (17-84)   \-   \-   \-    -   NM   NM   NM   
  Bener A.        1991-2003                   2006       Qatar    335      56.99±13.9   \-             NM   NM    -   \-   \-    -        

↑= a significant increasing; ↓= a significant decreasing; -= not significant change; NM= not mention in article.

M= male; F= female; HF= heart failure; AMI=acute myocardial infarction; UA= unstable angina; VHD= valvular heart disease.

Similarly, in a larger (though retrospective) series, Al Suwaidi et al. considered hospitalizations for heart failure during Ramadan compared with the rest of the year. Data were collected on 8446 Qatari patients (5095 males and 3351 females) for a period of 10 years (January 1991 through December 2001). There appeared to be no significant difference in the number of hospitalization for heart failure while fasting in Ramadan when compared to the non-fasting months.[@ref6]

Cardiometabolic risk factors {#sec2-2}
----------------------------

Blood pressure {#sec2-3}
--------------

[Table-II](#T2){ref-type="table"} summarizes the studies reporting the effects of Ramadan fasting on blood pressure. Three studies reported a significant reduction in systolic blood pressure during Ramadan compared to before Ramadan.[@ref12]-[@ref14] with the exception of a further study[@ref12], which reported a significant increase in pulse pressure, the majority of the studies evaluated revealed that there was no difference in blood pressure during and before Ramadan.

###### 

Effects of Ramadan fasting on blood pressure.

  Article     Subject's characteristics   Outcomes                                                                             
  ----------- --------------------------- ---------- ------------ ---- ---------- ----------- ----------- ---------- ---- ---- ----
  Habbal R.   1994-1997                   1998       NM           27   72         56.7±9      NM          NM         \-   \-   NM
  Perk G.     2001                        2001       Israel       17   56.6±6.9   NM          NM          \-         \-   NM   
  Rahman M.   2004                        2004       Bangladesh   20   0          NM          NM          NM         ↓    NM   ↑
  Ural E.     2007                        2008       Turkey       15   30         58±12       77.6±12.9   NM         \-   \-   NM
  Shehab      2012                        2012       UAE          70   32         38.7±10.5   82.9±14.6   28.1±4.4   ↓    \-   NM
  Nematy M.   2012                        2012       Iran         38   44         54±10       NM          NM         ↓    \-   NM

↑= a significant increasing; ↓= a significant decreasing; -= not significant change; NM= not mention in article.

M= male; F= female; BW= body weight; BMI= body mass index; SBP= systolic blood pressure;

DBP= diastolic blood pressure; PP= pulse pressure.

Body weight and composition {#sec2-4}
---------------------------

[Table-III](#T3){ref-type="table"} summarizes the studies which reported the effects of Ramadan fasting on body weight and composition. In addition, [Table-III](#T3){ref-type="table"} shows a significant reduction in BMI and Waist circumference collectively.[@ref12]-[@ref18]

###### 

Effects of Ramadan fasting on blood lipids and anthropometric parameters.

  Article        Subject's characteristics   Outcomes                                                                                                                          
  -------------- --------------------------- ---------- -------------- ---- ----- ------------ ----------- ------------ ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----
  Sulieman S.    1982                        1982       UK and Sudan   20   4     30 (21-40)   69.5±2.3    NM           NM   NM   NM   NM   ↑    \-   NM   NM   NM   ↓    NM   NM
  Hallak M. H.   1988                        1988       Syria          16   \-    18-30        66.2±7.6    22.5±2.6     ↑    NM   NM   NM   \-   ↓    ↓    ↑         ↓         NM
  Maislos M.     1992                        1993       Israel         16   8     27 (18-45)   68±17       24.6±4.6     NM   NM   NM   NM   \-   \-   ↑    \-   \-   \-   \-   NM
  Adlouni A.     1997                        1997       Moracco        32   \-    NM           NM          NM           ↑    NM   NM   NM   ↓    ↓    ↑    ↓    NM   ↓    NM   NM
  Maislos M.     1998                        1998       Israel         32   NM    NM           NM          NM           NM   NM   NM   \-   \-   ↑    \-   \-   NM   \-   NM   
  Ziaee V.       2002                        2002       Iran           41   39    20-35        62.4±11.6   21.2±4.5     NM   NM   NM   NM   \-   \-   ↓    ↑    \-   ↓    ↓    NM
  Afrasiabi A.   1997                        2003       Iran           28   0     NM           NM          NM           ↓    ↓    ↓    ↓    ↓    ↓    \-   ↓    NM   NM   ↓    NM
  Afrasiabi A.   1998                        2003       Iran           22   0     NM           NM          NM           ↓    NM   NM   NM   \-   ↓    \-   \-   \-   \-   \-   NM
  Ch-Pasha H.    1996                        2004       KSA            54   32    56 (17-84)   NM          NM           NM   NM   NM   NM   \-   \-   \-   \-   \-   NM   NM   NM
  Rahman M.      2004                        2004       Bangladesh     20   0     NM           NM          NM           ↑    NM   NM   ↑    \-   \-   ↑    \-   \-   ↓    ↓    NM
  Unalacak M.    2007                        2011       nm             10   0     NM           NM          NM           ↓    NM   NM   NM   ↓    ↓    ↑    ↓    ↓    ↓    ↓    NM
  Barkia A.      2011                        2011       Tunisia        19   6     42 (22-55)   NM          27.1±2.6     NM   NM   ↑    ↑    ↑    \-   ↑    \-   NM   NM   NM   NM
  Sadiya A.      2011                        2011       UAE            0    276   49±6         NM          34.63±3.29   \-   NM   ↓    ↑    NM   NM   NM   NM   NM   ↓    NM   ↓
  Shehab         2012                        2012       UAE            70   32    38.7±10.5    82.9±14.6   28.1±4.4          NM   NM   NM   \-   \-   ↑    ↓    NM   ↓    ↓    ↓
  Nematy M.      2012                        2012       Iran           38   44    54±10        NM          NM           \-   \-   \-   \-   ↓    ↓    ↑    ↓    ↓    ↓    ↓    ↓
  Mirzaei B.     2012                        2012       Iran           14   0     20.12±2.5    NM          70.61±18.4   NM   NM   NM   NM   ↓    \-   ↑    ↓    \-   ↓    NM   NM

↑= a significant increasing; ↓= a significant decreasing; -= not significant change; NM= not mention in article.M= male; F= female; BW= body weight; BMI= body mass index; EI= energy intake; CI= carbohydrate intake; PI= protein intake; FI= fat intake; T-chol= total cholesterol; TG= triglycerides; HDL= high density lipoproteins; LDL=low density lipoproteins; VLDL= very low density lipoproteins; WC= waist circumference.

Lipid profile {#sec2-5}
-------------

In terms of metabolic profile, five studies reported a significant decrease in total circulating cholesterol (T-chol) during the month of Ramadan.[@ref13],[@ref17],[@ref19]-[@ref21] This is in contrast with two studies which revealed a significant increase in T-chol during Ramadan.[@ref22],[@ref23]

Six studies reported a significant reduction in triglycerides during this period.[@ref13],[@ref15],[@ref17],[@ref19],[@ref20],[@ref24] The effects of fasting on high density lipoprotein (HDL) levels was equivocal, with nine studies reporting a significant increase during Ramadan[@ref12]-[@ref14],[@ref17],[@ref19],[@ref21],[@ref22],[@ref25],[@ref26] but two others reporting a decrease.[@ref25],[@ref27] A similar pattern was observed with low density lipoprotein (LDL). Six studies showed a significant decrease during Ramadan fasting.[@ref13]-[@ref15],[@ref17],[@ref19],[@ref21] but a further two studies reported an increase in LDL.[@ref24],[@ref16] Most of the studies included in this review reported no effect on very low density lipoprotein (VLDL) levels[@ref5],[@ref12],[@ref15],[@ref16],[@ref21],[@ref25],[@ref26] although two did report a significant decrease in VLDL.[@ref13],[@ref17]

DISCUSSION {#sec1-4}
==========

The high incidence of cardiovascular diseases in predominantly Muslim populations make an assessment of the effects of Ramadan on cardiovascular outcomes and parameters important. Broadly, the effects may be summarized as neutral or beneficial, although there are notable exceptions. For example, two studies in particular noted a deterioration in lipid profile during Ramadan fasting.[@ref16],[@ref24] Definitive answers are, however, difficult as long-term prospective data are lacking, and the literature comprises studies of generally small size. This latter limitation also confines outcome studies to populations in whom secondary prevention is considered, rather than primary prevention of cardiovascular disease.

Other limitations include the need to control for time of year. The timing of Ramadan moves throughout the year, in accordance with the phases of the moon. Therefore over a decade or so, one would anticipate fasting to have occurred throughout the year, and for seasonal influences on cardiovascular outcomes to be controlled. The short timeframe for many of the studies in the literature, however, introduces a complication and care must be taken in interpreting the results.

Many studies use individuals as their own controls, or are uncontrolled, introducing further limitations into the data. Comparison of fasting individuals with non-fasting individuals is problematic, as those who are exempted from fasting are generally exempted on the grounds of ill health. Randomization to fasting and non-fasting groups would be problematic, on the basis of interference with an individual's strongly held beliefs.

Furthermore, the global reach of Islam as a religion makes wider application of results from one part of the world, where there are specific local cultural and eating habits, to another region, where the habits are different. In addition, many of the studies fail to account for common confounders, such as the effects of smoking, and physical activity.

Therefore, inconsistency in the results of different investigations on the influences of Ramadan fasting on cardiometabolic risk factors and anthropometrics parameters can be explained by the mentioned reasons and limitations regarding the studies related to Ramadan including diverse food habits and socioeconomic status of different sets of Muslims, differences in climate and fasting duration between counties, difference in the methods of studies, races and genders of the subjects as well as dissimilar life style in different countries, health status and medical history of each participant. Future research should therefore concentrate on the investigation of these factors.

Perhaps insights might be gained by considering parallel situations in other religions, or the comparison of CR (Calorie restriction) and DR (Dietary restriction) dietary regimens with ADF (Alternate-Day Fasting) regimens. Studies have revealed that calorie restriction with adequate nutrition may have beneficial effects on several metabolic and molecular factors that are modulating cardiovascular aging itself[@ref27] and also improve lipid profile, blood pressure and fasting blood sugar.[@ref4],[@ref28],[@ref29] Furthermore, it has been indicated that Short-term modified alternate-day fasting can be a novel dietary strategy for weight loss and cardioprotection in normal weigh and overweight adults.[@ref30], [@ref31]

Areas on which further study may be focused include the effects of Ramadan fasting on metabolic diseases including diabetes, the components of metabolic syndrome, kidney diseases and liver diseases like fatty liver disease.

CONCLUSION {#sec1-5}
==========

The literature does not support the association of Ramadan fasting with any change in incidence of cardiovascular illness, and the majority of cardiovascular patients can fast except those with diabetes mellitus according to the unfavorable changes in lipid profile and the specific dietary regimens of these patients. Generally, the effect of Ramadan fasting on cardiovascular risk factors appears to be neutral, but with some studies reporting benefit on lipid parameters, and others on BMI.
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